Compared to the APE patients in Groups 1 and 2, those in Group 3 were relatively older, had a faster heart rate, lower systolic blood pressure, lower Alb and total cholesterol levels, higher NLP, lower LMR, and comorbidities such as right heart dilatation, heart failure, or a history of DVT. The gene discussed is ALB; the disease is heart failure.